A reversible, cell-permeable inhibitor of JARID1 family demethylases (IC<sub>50</sub>s = 6, 3, 4.9, and 28 µM for JARID1A, JARID1B, JARID1C, and JARID1D, respectively) increases trimethylation of H3K4 in HeLa cells and blocks the
A reversible, cell-permeable inhibitor of JARID1 family demethylases (IC<sub>50</sub>s = 6, 3, 4.9, and 28 µM for JARID1A, JARID1B, JARID1C, and JARID1D, respectively) increases trimethylation of H3K4 in HeLa cells and blocks the
A potent inhibitor of VEGFR1, 2, and 3 (IC50s = 5, 1, and 3 nM, respectively) also potently inhibits a variety of other receptor and non-receptor tyrosine kinases blocks tubule formation by HUVECs in vitro and prevents angiogenesis as well as
A potent inhibitor of VEGFR1, 2, and 3 (IC50s = 5, 1, and 3 nM, respectively) also potently inhibits a variety of other receptor and non-receptor tyrosine kinases blocks tubule formation by HUVECs in vitro and prevents angiogenesis as well as
A non-lipid inhibitor of cellular ceramidase activity (IC50 = 28 &muM in a cell-based assay) induces the accumulation of endogenous ceramide species and decreases intracellular levels of sphingosine and S1P inhibits cell proliferation of ovarian
A non-lipid inhibitor of cellular ceramidase activity (IC50 = 28 &muM in a cell-based assay) induces the accumulation of endogenous ceramide species and decreases intracellular levels of sphingosine and S1P inhibits cell proliferation of ovarian
A centrally acting M1 muscarinic acetylcholine receptor antagonist (Ki = 0.59 nM in rat) that also inhibits dopamine uptake through the dopamine transporter (Ki = 160 nM) used in the management of Parkinson&rsquos disease symptoms to address
A centrally acting M1 muscarinic acetylcholine receptor antagonist (Ki = 0.59 nM in rat) that also inhibits dopamine uptake through the dopamine transporter (Ki = 160 nM) used in the management of Parkinson&rsquos disease symptoms to address
The kinesin-like spindle protein Eg5 (also known as kinesin-5, kinesin family protein 11, or Kif11) is a motor protein that is essential for establishing a bipolar spindle during mitosis both in normal and tumor cells. Ispinesib is a cell-permeable,
The kinesin-like spindle protein Eg5 (also known as kinesin-5, kinesin family protein 11, or Kif11) is a motor protein that is essential for establishing a bipolar spindle during mitosis both in normal and tumor cells. Ispinesib is a cell-permeable,
The kinesin-like spindle protein Eg5 (also known as kinesin-5, kinesin family protein 11, or Kif11) is a motor protein that is essential for establishing a bipolar spindle during mitosis both in normal and tumor cells. Ispinesib is a cell-permeable,
The kinesin-like spindle protein Eg5 (also known as kinesin-5, kinesin family protein 11, or Kif11) is a motor protein that is essential for establishing a bipolar spindle during mitosis both in normal and tumor cells. Ispinesib is a cell-permeable,
A centrally acting M1 muscarinic acetylcholine receptor antagonist (Ki = 0.59 nM in rat) that also inhibits dopamine uptake through the dopamine transporter (Ki = 160 nM) used in the management of Parkinson&rsquos disease symptoms to address
A centrally acting M1 muscarinic acetylcholine receptor antagonist (Ki = 0.59 nM in rat) that also inhibits dopamine uptake through the dopamine transporter (Ki = 160 nM) used in the management of Parkinson&rsquos disease symptoms to address
A non-lipid inhibitor of cellular ceramidase activity (IC50 = 28 &muM in a cell-based assay) induces the accumulation of endogenous ceramide species and decreases intracellular levels of sphingosine and S1P inhibits cell proliferation of ovarian
A non-lipid inhibitor of cellular ceramidase activity (IC50 = 28 &muM in a cell-based assay) induces the accumulation of endogenous ceramide species and decreases intracellular levels of sphingosine and S1P inhibits cell proliferation of ovarian